Correlation Between Mink Therapeutics and Equillium
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Equillium, you can compare the effects of market volatilities on Mink Therapeutics and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Equillium.
Diversification Opportunities for Mink Therapeutics and Equillium
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Mink and Equillium is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Equillium go up and down completely randomly.
Pair Corralation between Mink Therapeutics and Equillium
Given the investment horizon of 90 days Mink Therapeutics is expected to under-perform the Equillium. But the stock apears to be less risky and, when comparing its historical volatility, Mink Therapeutics is 1.98 times less risky than Equillium. The stock trades about -0.34 of its potential returns per unit of risk. The Equillium is currently generating about -0.16 of returns per unit of risk over similar time horizon. If you would invest 85.00 in Equillium on September 13, 2024 and sell it today you would lose (15.00) from holding Equillium or give up 17.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mink Therapeutics vs. Equillium
Performance |
| Timeline |
| Mink Therapeutics |
| Equillium |
Mink Therapeutics and Equillium Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mink Therapeutics and Equillium
The main advantage of trading using opposite Mink Therapeutics and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.| Mink Therapeutics vs. Puma Biotechnology | Mink Therapeutics vs. Iovance Biotherapeutics | Mink Therapeutics vs. Sarepta Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
| Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |